Clinical Trial Update: Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study [Phase 4]

View source ↗

Summary

Phase 4 pharmacodynamic study of desmopressin melt therapy in nocturia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin melt therapy (desmopressin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Nocturia | Phase 4 | Status: COMPLETED